Biofrontera (BFRI) Net Cash Flow (QoQ) (2021 - 2025)
Biofrontera (BFRI) Net Cash Flow (QoQ) (2021 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.97 Bn | 36.23 Bn | 1.97 Bn |
| 2 | Zoetis | 33.59 Bn | 31.65 Bn | 1.62 Bn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn |
| 4 | Neurocrine Biosciences | 16.10 Bn | 14.78 Bn | 800.70 Mn |
| 5 | Aurora Cannabis | 15.56 Bn | 15.47 Bn | 21.72 Mn |
| 6 | Elanco Animal Health | 12.04 Bn | 11.61 Bn | 785.00 Mn |
| 7 | Alkermes | 7.36 Bn | 6.84 Bn | -116.06 Mn |
| 8 | Lantheus Holdings | 6.74 Bn | 6.24 Bn | 230.92 Mn |
| 9 | Liquidia | 6.27 Bn | 6.04 Bn | 121.79 Mn |
| 10 | Biofrontera | 8.81 Mn | 2.40 Mn | 14.09 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 177.59% |
| Sep 30, 2025 | -22.03% |
| Jun 30, 2025 | 24.42% |
| Mar 31, 2025 | -235.32% |
| Dec 31, 2024 | 301.33% |
| Sep 30, 2024 | -367.02% |
| Jun 30, 2024 | -77.20% |
| Mar 31, 2024 | 218.71% |
| Dec 31, 2023 | -102.13% |
| Sep 30, 2023 | 89.84% |
| Jun 30, 2023 | -173.21% |
| Mar 31, 2023 | 64.14% |
| Dec 31, 2022 | -138.39% |
| Sep 30, 2022 | -4,722.34% |
| Jun 30, 2022 | 104.44% |
| Mar 31, 2022 | -109.27% |
| Dec 31, 2021 | 1,797.40% |
| Sep 30, 2021 | -27.25% |
| Jun 30, 2021 | 69.30% |
| Mar 31, 2021 | -194.48% |